L9

Azemidite Biopharm Co., Ltd, established in 2017 and based in Tianjin, manufactures pharmaceutical intermediates and offers pharmaceutical outsourcing, customized development and consulting services, including CMO, CSO and CDMO contract manufacturing under OEM, ODM and own-brand models. The company positions itself around providing high value-added services to customers, selling on FOB, CIF and EXW terms with T/T payment across North and South America, Western and Eastern Europe, Asia, Australasia, the Middle East and Africa, backed by brand recognition, an experienced R&D team, solid production capacity and a broad product line.